These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14680611)

  • 1. [Study on the treatment of high dose mifepristone and progesterone in endometrial carcinoma].
    Li CZ; Wen ZQ; Lan SM; Wang JY; Liu Y
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):552-5. PubMed ID: 14680611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma].
    Chen YP; Shen M; Chen C
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44V6 and PCNA in squamous cell carcinomas.
    Niu Y; Liu F; Zhou Z; Wang H
    Chin Med J (Engl); 2002 Oct; 115(10):1564-8. PubMed ID: 12490112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of daily low dose mifepristone on endometrial maturation and proliferation.
    Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT
    Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
    Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
    Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of progesterone on expression of ER, PR, PCNA, bcl-2, c-myc, c-fos, and EGFR in normal breast tissue implanted into nude mice].
    Deng WH; Du J; Yang L; He SR; Sun R; Wu YY
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(35):2827-2831. PubMed ID: 30248787
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of estrogen and progesterone receptors in endometrial carcinoma].
    Chen Y; Peng Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):98-100. PubMed ID: 12501628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
    Wang X; Huang Z; Di W; Lin Q
    Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
    Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acetate administration for endometrial hyperplasias.
    Masuzawa H; Badokhon NH; Nakayama K; Konishi I; Nikaido T; Fujii S
    Cancer; 1994 Oct; 74(8):2321-8. PubMed ID: 7922983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
    Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
    Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral effects of medroxy-progesterone on proliferation, apoptosis, and sex steroid receptors in endometrioid endometrial adenocarcinoma.
    Dahmoun M; Boman K; Cajander S; Bäckström T
    Gynecol Oncol; 2004 Jan; 92(1):116-26. PubMed ID: 14751147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endometrial cancer cell lines by mifepristone (RU 486).
    Schneider CC; Gibb RK; Taylor DD; Wan T; Gerçel-Taylor C
    J Soc Gynecol Investig; 1998; 5(6):334-8. PubMed ID: 9824816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.